CIP
PHAT icon

Chartwell Investment Partners’s Phathom Pharmaceuticals PHAT Stock Holding History

Chartwell Investment Partners’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$396K Buy
+21,904
New +$306K 0.01% 406
2022
Q3 		– Sell
-68,236
Closed -$576K – 430
2022
Q2 		$576K Buy
68,236
+37,646
+123% +$387K 0.02% 391
2022
Q1 		$416K Buy
30,590
+8,396
+38% +$136K 0.01% 406
2021
Q4 		$437K Sell
22,194
-395
-2% -$9.3K 0.01% 416
2021
Q3 		$725K Hold
22,589
– – 0.02% 396
2021
Q2 		$765K Buy
+22,589
New +$809K 0.02% 391

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Chartwell Investment Partners's PHAT Position: Q3 2024 in Review

Chartwell Investment Partners opened a new position in Phathom Pharmaceuticals (PHAT) in Q3 2024: 21,904 shares worth $396K. The stake represents 0.01% of the portfolio and ranks #406 among its holdings. This is a return to the name: Chartwell Investment Partners previously reported a position in PHAT as recently as Q2 2022.

Chartwell Investment Partners first reported a position in PHAT in Q2 2021 and has held it in 6 quarters since. The position peaked at $765K in Q2 2021. 133 funds tracked by Wall St. Rank hold PHAT as of Q3 2024.

  • Chartwell Investment Partners held 21,904 shares of Phathom Pharmaceuticals worth $396K as of Q3 2024.
  • Phathom Pharmaceuticals was a new Chartwell Investment Partners position in Q3 2024.
  • Phathom Pharmaceuticals made up 0.01% of Chartwell Investment Partners's portfolio in Q3 2024, its #406 holding.
  • Chartwell Investment Partners first reported a position in Phathom Pharmaceuticals in Q2 2021 and has held it in 6 quarters since.
  • Chartwell Investment Partners's Phathom Pharmaceuticals position peaked at $765K in Q2 2021.
  • 133 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q3 2024.

Based on Chartwell Investment Partners's 13F filing for Q3 2024, filed 4 Nov 2024.